日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial

心力衰竭患者死亡方式前的生物标志物、功能状态和生活质量轨迹:FINEARTS-HF随机临床试验的事后分析

Lu, Henri; Kosztin, Annamaria; Claggett, Brian L; Foà, Alberto; Pabón, Maria A; Desai, Akshay S; Jhund, Pardeep S; Henderson, Alasdair D; Merkely, Bela; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; Amarante, Flaviana; Saarinen, Riitta; De Sanctis, Yoriko; Glasauer, Andrea; McMurray, John J V; Vaduganathan, Muthiah; Solomon, Scott D

Effect of Finerenone on Morbidity and Mortality in CKD

非奈利酮对慢性肾脏病患者发病率和死亡率的影响

Ostrominski, John W; Filippatos, Gerasimos; Claggett, Brian L; Miao, Zi Michael; Desai, Akshay S; Jhund, Pardeep S; Henderson, Alasdair; Rohwedder, Katja; Brinker, Meike D; Scalise, Andrea; Schloemer, Patrick; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Rossing, Peter; Ruilope, Luis M; Anker, Stefan D; Pitt, Bertram; Agarwal, Rajiv; McMurray, John J V; Solomon, Scott D; Vaduganathan, Muthiah

Finerenone and eGFR Slope across Different Levels of Baseline Albuminuria and eGFR: Insights from FINEARTS-HF

非奈利酮和eGFR斜率在不同基线白蛋白尿和eGFR水平下的变化:来自FINEARTS-HF研究的启示

Mc Causland, Finnian R; Heerspink, Hiddo J L; Vaduganathan, Muthiah; Claggett, Brian L; Desai, Akshay S; Jhund, Pardeep S; McGrath, Martina M; Rohwedder, Katja; Amarante, Flaviana; Brinker, Meike; Schloemer, Patrick; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; McMurray, John J V; Solomon, Scott D

IGFBP7 and Heart Failure: From Senescence Biomarker to Therapeutic Target

IGFBP7与心力衰竭:从衰老生物标志物到治疗靶点

El-Qendouci, Maissa; Chelu, Raluca; Abdellatif, Mahmoud; Jhund, Pardeep; de Boer, Rudolf A; Suthahar, Navin

Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fraction

射血分数轻度降低或保留的心力衰竭患者接受综合药物治疗的终身益处

Vaduganathan, Muthiah; Claggett, Brian L; Chatur, Safia; Desai, Akshay S; Jhund, Pardeep S; Vardeny, Orly; Merkely, Bela; Martinez, Felipe; Comin-Colet, Josep; Kerr Saraiva, Jose F; Shah, Sanjiv J; Lam, Carolyn S P; Zannad, Faiez; Docherty, Kieran F; McMurray, John J V; Solomon, Scott D

Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

射血分数轻度降低或保留的心力衰竭患者中,心力衰竭事件、新发糖尿病和非奈利酮之间的相互作用

Ostrominski, John W; Lu, Henri; Claggett, Brian L; Desai, Akshay S; Jhund, Pardeep S; Henderson, Alasdair D; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; Brinker, Meike; Schloemer, Patrick; Rohwedder, Katja; McMurray, John J V; Solomon, Scott D; Vaduganathan, Muthiah

Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial

口服索马鲁肽对 2 型糖尿病患者心力衰竭结局的影响:SOUL 随机临床试验的二次分析

Pop-Busui, Rodica; Rasmussen, Søren; Deanfield, John E; Buse, John B; Marx, Nikolaus; Mulvagh, Sharon L; Inzucchi, Silvio E; Mann, Johannes F E; Emerson, Scott S; Poulter, Neil R; Engelmann, Mads D M; Hovingh, G Kees; Bayer Tanggaard, Katrine; Birkenfeld, Andreas L; Connelly, Kim A; Haluzik, Martin; Cavender, Matthew A; Kellerer, Monika; Jhund, Pardeep S; Gregersen, Søren; Nielsen, Olav Wendelboe; Lam, Carolyn S P; McGuire, Darren K

EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HF

EMPEROR 保留风险模型与 FINEARTS-HF 试验结果:FINEARTS-HF 试验的预设二次分析

Chimura, Misato; McDowell, Kirsty; Jhund, Pardeep S; Henderson, Alasdair D; Claggett, Brian L; Desai, Akshay S; Brinker, Meike; Lay-Flurrie, James; Glasauer, Andrea; Goea, Laura; Berger, Mario; Lam, Carolyn S P; Senni, Michele; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; Vaduganathan, Muthiah; Solomon, Scott D; McMurray, John J V

Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure

非甾体类MRA非奈利酮联合或不联合SGLT2抑制剂治疗心力衰竭的效果

Vaduganathan, Muthiah; Claggett, Brian L; Kulac, Ian J; Miao, Zi Michael; Desai, Akshay S; Jhund, Pardeep S; Henderson, Alasdair D; Brinker, Meike; Lay-Flurrie, James; Viswanathan, Prabhakar; Scheerer, Markus Florian; Lage, Andrea; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; McMurray, John J V; Solomon, Scott D

Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial

非奈利酮治疗射血分数轻度降低或保留的心力衰竭患者的疗效和安全性:FINEARTS-HF试验的预设分析

Docherty, Kieran F; Henderson, Alasdair D; Jhund, Pardeep S; Claggett, Brian L; Desai, Akshay S; Mueller, Katharina; Viswanathan, Prabhakar; Scalise, Andrea; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Pitt, Bertram; Vaduganathan, Muthiah; Solomon, Scott D; McMurray, John J V